National Guideline Clearinghouse | Guidelines by Topic: Sexually Transmitted Diseases 3

National Guideline Clearinghouse | Guidelines by Topic: Sexually Transmitted Diseases

Guidelines by Topic

Disease/Condition > Diseases (1818) > Virus Diseases (162) >

Sexually Transmitted Diseases (93)

Narrow:

Sexually Transmitted Diseases, Viral (79)

41-60 of 93   < Previous | Next >
41.   HIV disclosure to parents and consent to HIV treatment among adolescents. 2012 Nov. NGC:009560 New York State Department of Health - State/Local Government Agency [U.S.]. View all guidelines by thedeveloper(s) Compare Selected
42.   HIV prophylaxis following occupational exposure. 2003 Mar (revised 2012 Oct). NGC:009558 New York State Department of Health - State/Local Government Agency [U.S.]. View all guidelines by thedeveloper(s) Compare Selected
43.   Kidney disease in HIV-infected patients. 2012 Sep. NGC:009559 New York State Department of Health - State/Local Government Agency [U.S.]. View all guidelines by thedeveloper(s) Compare Selected
44.   Trichomoniasis. 2012 Aug. NGC:009561 New York State Department of Health - State/Local Government Agency [U.S.]. View all guidelines by thedeveloper(s) Compare Selected
45.   (1) U.S. medical eligibility criteria for contraceptive use, 2010: adapted from the World Health Organization medical eligibility criteria for contraceptive use, 4th edition. (2) Update to CDC's U.S. medical eligibility criteria for contraceptive use, 2010: revised recommendations for the use of contraceptive methods during the postpartum period. (3) Update to CDC's U.S. medical eligibility criteria for contraceptive use, 2010: revised recommendations for the use of hormonal contraception among women at high risk for HIV infection or infected with HIV. 2010 Jun 18 (addenda released 2011 Jul 8 and 2012 Jun 22). NGC:009194 Centers for Disease Control and Prevention - Federal Government Agency [U.S.]. View all guidelines by thedeveloper(s) Compare Selected
46.   Canadian HIV pregnancy planning guidelines. 2012 Jun. NGC:009153 Society of Obstetricians and Gynaecologists of Canada - Medical Specialty Society. View all guidelines by thedeveloper(s) Compare Selected
47.   Clinical Pharmacogenetics Implementation Consortium guidelines for HLA-B genotype and abacavir dosing. 2012 Apr (reaffirmed 2014). NGC:009587 Clinical Pharmacogenetics Implementation Consortium - Independent Expert Panel. View all guidelines by thedeveloper(s) Compare Selected
48.   Guidelines for improving entry into and retention in care and antiretroviral adherence for persons with HIV: evidence-based recommendations from an International Association of Physicians in AIDS Care panel. 2012 Jun 5. NGC:009108 International Association of Physicians in AIDS Care - Professional Association. View all guidelines by thedeveloper(s) Compare Selected
49.   Care of the HIV-infected transgender patient. 2011 Jul (revised 2012 Jan). NGC:009206 New York State Department of Health - State/Local Government Agency [U.S.]. View all guidelines by thedeveloper(s) Compare Selected
50.   Dementia in the long term care setting. 1998 (revised 2012). NGC:009847 American Medical Directors Association - Professional Association. View all guidelines by the developer(s) Compare Selected
51.   Evidence-based guideline: antiepileptic drug selection for people with HIV/AIDS. Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Ad Hoc Task Force of the Commission on Therapeutic Strategies of the International League Against Epilepsy. 2012 Jan 10. NGC:009069 American Academy of Neurology - Medical Specialty Society; International League Against Epilepsy - Disease Specific Society. View all guidelines by the developer(s) Compare Selected
52.   Perioperative management of HIV-infected patients. 2012 Jan. NGC:009208 New York State Department of Health - State/Local Government Agency [U.S.]. View all guidelines by thedeveloper(s) Compare Selected
53.   WHO policy on collaborative TB/HIV activities. Guidelines for national programmes and other stakeholders. 2012. NGC:009145 World Health Organization - International Agency. View all guidelines by the developer(s) Compare Selected
54.   New antiretroviral drugs: maraviroc, raltegravir, etravirine, and rilpivirine. 2008 Apr (revised 2011 Nov). NGC:008821 New York State Department of Health - State/Local Government Agency [U.S.]. View all guidelines by thedeveloper(s) Compare Selected
55.   Syphilis. 2009 Jan (revised 2011 Oct). NGC:008820 New York State Department of Health - State/Local Government Agency [U.S.]. View all guidelines by thedeveloper(s) Compare Selected
56.   Mycobacterium avium complex and Mycobacterium kansasii. In: British HIV Association and British Infection Association guidelines for the treatment of opportunistic infection in HIV-seropositive individuals 2011. 2011 Sep. NGC:010339 British HIV Association - Disease Specific Society; British Infection Association - Professional Association. View all guidelines by the developer(s) Compare Selected
57.   Acute HIV infection in pregnancy. 2011 Sep. NGC:008811 New York State Department of Health - State/Local Government Agency [U.S.]. View all guidelines by thedeveloper(s) Compare Selected
58.   Candidiasis. In: British HIV Association and British Infection Association guidelines for the treatment of opportunistic infection in HIV-seropositive individuals 2011. 2011 Sep. NGC:010338 British HIV Association - Disease Specific Society; British Infection Association - Professional Association. View all guidelines by the developer(s) Compare Selected
59.   Central nervous system opportunistic infections. In: British HIV Association and British Infection Association guidelines for the treatment of opportunistic infection in HIV-seropositive individuals 2011.2011 Sep. NGC:010332 British HIV Association - Disease Specific Society; British Infection Association - Professional Association. View all guidelines by the developer(s) Compare Selected
60.   Gastrointestinal opportunistic infections. In: British HIV Association and British Infection Association guidelines for the treatment of opportunistic infection in HIV-seropositive individuals 2011. 2011 Sep. NGC:010335 British HIV Association - Disease Specific Society; British Infection Association - Professional Association. View all guidelines by the developer(s)